Craig-Hallum Maintains Buy on MiMedx Group, Lowers Price Target to $7

Benzinga Newsdesk www.benzinga.com Negative 61.7%

Neg 61.7% Neu 0% Pos 0%

Craig-Hallum analyst Chase Knickerbocker maintains MiMedx Group (NASDAQ:MDXG) with a Buy and lowers the price target from $10 to $7.